HU216863B - Eljárás bioaktív anyagok immunológiai aktivitásának meghatározására - Google Patents

Eljárás bioaktív anyagok immunológiai aktivitásának meghatározására Download PDF

Info

Publication number
HU216863B
HU216863B HU9401185A HU9401185A HU216863B HU 216863 B HU216863 B HU 216863B HU 9401185 A HU9401185 A HU 9401185A HU 9401185 A HU9401185 A HU 9401185A HU 216863 B HU216863 B HU 216863B
Authority
HU
Hungary
Prior art keywords
ttp
pbl
cytokine
medium
ifn
Prior art date
Application number
HU9401185A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT69990A (en
HU9401185D0 (en
Inventor
Zofia Blach-Olszewska
Anna Inglot
Original Assignee
Torf Establishment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Establishment filed Critical Torf Establishment
Publication of HU9401185D0 publication Critical patent/HU9401185D0/hu
Publication of HUT69990A publication Critical patent/HUT69990A/hu
Publication of HU216863B publication Critical patent/HU216863B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HU9401185A 1991-10-26 1992-09-28 Eljárás bioaktív anyagok immunológiai aktivitásának meghatározására HU216863B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances

Publications (3)

Publication Number Publication Date
HU9401185D0 HU9401185D0 (en) 1994-07-28
HUT69990A HUT69990A (en) 1995-09-28
HU216863B true HU216863B (hu) 1999-09-28

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401185A HU216863B (hu) 1991-10-26 1992-09-28 Eljárás bioaktív anyagok immunológiai aktivitásának meghatározására

Country Status (22)

Country Link
US (1) US5543300A (enEXAMPLES)
EP (2) EP0539610A1 (enEXAMPLES)
JP (1) JPH07500905A (enEXAMPLES)
AT (1) ATE153763T1 (enEXAMPLES)
AU (1) AU678343B2 (enEXAMPLES)
BG (1) BG61705B1 (enEXAMPLES)
CA (1) CA2122131A1 (enEXAMPLES)
CZ (1) CZ100494A3 (enEXAMPLES)
DE (3) DE539610T1 (enEXAMPLES)
DK (1) DK0609255T3 (enEXAMPLES)
ES (1) ES2061424T3 (enEXAMPLES)
FI (1) FI941920A0 (enEXAMPLES)
GR (3) GR930300100T1 (enEXAMPLES)
HU (1) HU216863B (enEXAMPLES)
LV (1) LV12140B (enEXAMPLES)
NO (1) NO941444L (enEXAMPLES)
PL (1) PL170592B1 (enEXAMPLES)
RO (1) RO114837B1 (enEXAMPLES)
RU (1) RU2125727C1 (enEXAMPLES)
SG (1) SG72665A1 (enEXAMPLES)
SK (1) SK44094A3 (enEXAMPLES)
WO (1) WO1993008470A1 (enEXAMPLES)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
WO2000016785A2 (en) * 1998-09-23 2000-03-30 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DE60304989T2 (de) * 2003-02-18 2007-03-29 Clinique La Prairie Research S.A. Zusammensetzungen enthaltend fötales Hämoglobin und bakterielles Endotoxin und fakultativ zusätzliche fötale Leberkomponenten
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
EP2753422A1 (en) 2011-09-07 2014-07-16 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
ATE77488T1 (de) * 1986-03-06 1992-07-15 Commw Scient Ind Res Org In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
ATE131859T1 (de) * 1991-03-16 1996-01-15 Torf Ets Verfahren zur kontinuierlichen extraction von torf und apparat zur durchführung dieses verfahrens

Also Published As

Publication number Publication date
US5543300A (en) 1996-08-06
ES2061424T3 (es) 1997-10-01
HK1002610A1 (en) 1998-09-04
CZ100494A3 (en) 1994-11-16
SK44094A3 (en) 1995-03-08
EP0609255A1 (en) 1994-08-10
LV12140B (lv) 1998-12-20
DE69220078D1 (de) 1997-07-03
PL170592B1 (en) 1997-01-31
DE539610T1 (de) 1993-12-16
AU2650992A (en) 1993-05-21
LV12140A (lv) 1998-09-20
GR940300077T1 (en) 1994-11-30
DK0609255T3 (da) 1997-12-22
JPH07500905A (ja) 1995-01-26
DE609255T1 (de) 1995-06-14
AU678343B2 (en) 1997-05-29
GR930300100T1 (enEXAMPLES) 1993-10-29
RO114837B1 (ro) 1999-07-30
ATE153763T1 (de) 1997-06-15
BG61705B1 (bg) 1998-03-31
HUT69990A (en) 1995-09-28
RU94022481A (ru) 1996-09-27
BG98720A (bg) 1995-07-28
HU9401185D0 (en) 1994-07-28
ES2061424T1 (es) 1994-12-16
CA2122131A1 (en) 1993-04-29
WO1993008470A1 (en) 1993-04-29
NO941444L (no) 1994-06-16
SG72665A1 (en) 2000-05-23
RU2125727C1 (ru) 1999-01-27
FI941920A7 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
GR3024457T3 (en) 1997-11-28
EP0539610A1 (en) 1993-05-05
EP0609255B1 (en) 1997-05-28
FI941920L (fi) 1994-04-25
NO941444D0 (no) 1994-04-21
FI941920A0 (fi) 1994-04-25

Similar Documents

Publication Publication Date Title
Sorrell et al. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro
Ogra et al. Immunologic aspects of human colostrum and milk: II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation
Kelso et al. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
Franke-Ullmann et al. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro.
HU216863B (hu) Eljárás bioaktív anyagok immunológiai aktivitásának meghatározására
Roberts Jr et al. Hyperthermia and human leukocyte function: II. Enhanced production of and response to leukocyte migration inhibition factor (LIF)
Laszlo et al. Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer
HILL et al. Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis
Ferrante et al. Depression of human polymorphonuclear leucocyte function by anti-malarial drugs
Oh et al. Cooperation between CD16 (Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
Levin et al. Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells
Rinehart et al. Phase I/II trial of interferon-β-serine in patients with renal cell carcinoma; immunological and biological effects
Feldman et al. Functional deficiencies in two distinct interferon α-producing cell populations in peripheral blood mononuclear cells from human immunodeficiency virus seropositive patients
Bacon et al. Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies
Schwers et al. Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus
Ingimarsson et al. Immune Reactions and Long‐Term Therapy with Human Leukocyte Interferon
Torre et al. Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1
Gilles et al. Studies on the Significance of High Serum Gamma-Globulin Concentrations in Gambian Africans: III.—Gamma-Globulin Concentrations of Gambian Women Protected from Malaria for Two Years
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
EP1038529A2 (en) Agent for increasing chemokine production
Chapman et al. The two-step leukocyte migration inhibition factor (LIF) assay: Its use in evaluation of cellular immune function in patients with immunodeficiency diseases
Schattner et al. (2'-5') oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections
Schiller et al. Effects of Combinations of Interferon-βser and Interferon-γ on Interferon-Inducible Proteins and on the Cell Cycle
JP2813356B2 (ja) ウィルス病予防・治療剤およびインターフェロン産生増強法
Green et al. Spontaneous and induced interferon production by peripheral blood mononuclear leukocytes from humans with herpes labialis.

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee